Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randall J Bateman

Showing results (71-80 of 391) with videos related to

Pageof 40
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 24, 2022
Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performanceAlexa Pichet Binette, Shorena Janelidze, Nicholas Cullen, et al.
Alzheimer'S Research & Therapy|December 21, 2022
Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept studyEric McDade, Jeffrey L Cummings, Shobha Dhadda, et al.
Neuroscience Letters|August 3, 2017
A novel PSEN1 (S230N) mutation causing early-onset Alzheimer's Disease associated with prosopagnosia, hoarding, and ParkinsonismJohn M Ringman, Maria Casado, Victoria Van Berlo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 19, 2019
Staging biomarkers in preclinical autosomal dominant Alzheimer's disease by estimated years to symptom onsetGuoqiao Wang, Dean Coble, Eric M McDade, et al.
Alzheimer'S Research & Therapy|January 8, 2022
Plasma MCP-1 and changes on cognitive function in community-dwelling older adultsJuan Luis Sanchez-Sanchez, Kelly V Giudici, Sophie Guyonnet, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 19, 2023
Design and feasibility of an Alzheimer's disease blood test study in a diverse community-based populationMelody Li, Yan Li, Suzanne E Schindler, et al.
Neurology|August 8, 2020
Association of education with Aβ burden in preclinical familial and sporadic Alzheimer diseaseJulie Gonneaud, Christophe Bedetti, Alexa Pichet Binette, et al.
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Harnessing Greater Statistical Power: Comprehensive Evaluation of Disease Modifying Treatment Effects Across All or Multiple Post-Baseline Visits Compared to the Last Visit for Alzheimer's Disease Clinical TrialsGuoqiao Wang, Tianle Chen, John O'Gorman, et al.
JCI Insight|December 7, 2021
Astrocytic 4R tau expression drives astrocyte reactivity and dysfunctionLubov A Ezerskiy, Kathleen M Schoch, Chihiro Sato, et al.
Archives of Neurology|September 14, 2011
Effects of age and amyloid deposition on Aβ dynamics in the human central nervous systemYafei Huang, Rachel Potter, Wendy Sigurdson, et al.
Pageof 40

Showing results (71-80 of 391) with videos related to

Sort By:
Pageof 40
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 24, 2022
Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performanceAlexa Pichet Binette, Shorena Janelidze, Nicholas Cullen, et al.
Alzheimer'S Research & Therapy|December 21, 2022
Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept studyEric McDade, Jeffrey L Cummings, Shobha Dhadda, et al.
Neuroscience Letters|August 3, 2017
A novel PSEN1 (S230N) mutation causing early-onset Alzheimer's Disease associated with prosopagnosia, hoarding, and ParkinsonismJohn M Ringman, Maria Casado, Victoria Van Berlo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 19, 2019
Staging biomarkers in preclinical autosomal dominant Alzheimer's disease by estimated years to symptom onsetGuoqiao Wang, Dean Coble, Eric M McDade, et al.
Alzheimer'S Research & Therapy|January 8, 2022
Plasma MCP-1 and changes on cognitive function in community-dwelling older adultsJuan Luis Sanchez-Sanchez, Kelly V Giudici, Sophie Guyonnet, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 19, 2023
Design and feasibility of an Alzheimer's disease blood test study in a diverse community-based populationMelody Li, Yan Li, Suzanne E Schindler, et al.
Neurology|August 8, 2020
Association of education with Aβ burden in preclinical familial and sporadic Alzheimer diseaseJulie Gonneaud, Christophe Bedetti, Alexa Pichet Binette, et al.
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Harnessing Greater Statistical Power: Comprehensive Evaluation of Disease Modifying Treatment Effects Across All or Multiple Post-Baseline Visits Compared to the Last Visit for Alzheimer's Disease Clinical TrialsGuoqiao Wang, Tianle Chen, John O'Gorman, et al.
JCI Insight|December 7, 2021
Astrocytic 4R tau expression drives astrocyte reactivity and dysfunctionLubov A Ezerskiy, Kathleen M Schoch, Chihiro Sato, et al.
Archives of Neurology|September 14, 2011
Effects of age and amyloid deposition on Aβ dynamics in the human central nervous systemYafei Huang, Rachel Potter, Wendy Sigurdson, et al.
Pageof 40